Table 2:
Median values of cytokines and cytokine receptors in the 1st and 2nd visit before and after the treatment with celecoxib and etoricoxib in the respective group and in the control group. Values are in pg/ml
| Celecoxib group | Etoricoxib group | Control group | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1st visit Median (IQR) | 2nd visit Median (IQR) | p | 1st visit Median (IQR) | 2nd visit Median (IQR) | p | 1st visit Median (IQR) | 2nd visit Median (IQR) | p | |
| IL1β S | 0.24 (0.56) | 0.15 (0.12) | NS | 0.45 (0.51) | 0.23 (0.18) | 0.045 | 0.19 (0.19) | 0.21 (0.31) | NS |
| IL1β JF | 0.65 (0.92) | 0.20 (0.62) | NS | 2.30 (5.77) | 1.60 (5.85) | NS | 0.40 (0.43) | 0.54 (0.88) | 0.001 |
| IL1Ra S | 240.0 (180.0) | 250.0 (110.0) | NS | 250.0 (195.0) | 230.0 (295.0) | NS | 460.0 (740.0) | 710.0 (940.0) | NS |
| IL1Ra JF | 340.0 (2210.0) | 460.0 (5000.0) | <0.001 | 460.0 (8210.0) | 1100.0 (8600.0) | NS | 450.0 (1475.0) | 400.0 (1095.0) | NS |
| IL6 S | 1.30 (2.34) | 1.20 (1.67) | 0.003 | 1.70 (9.38) | 1.35 (9.55) | NS | 1.65 (1.10) | 1.60 (1.80) | NS |
| IL6 JF | 500.0 (5010.0) | 420.0 (2065.0) | 0.017 | 1450.0 (11360.0) | 880.0 (3140.0) | 0.019 | 300.0 (1300.0) | 300.0 (1340.0) | NS |
| TNF-α S | 1.20 (0.60) | 1.10 (0.40) | NS | 1.70 (1.00) | 1.10 (1.40) | NS | 1.30 (0.40) | 1.30 (0.35) | NS |
| TNF-α JF | 1.50 (2.89) | 1.00 (3.10) | NS | 2.90 (5.15) | 1.40 (3.70) | NS | 1.10 (1.25) | 1.70 (2.80) | 0.01 |
| sTNFR1 S | 1650.0 (500.0) | 1450.0 (450.0) | NS | 2000.0 (1200.0) | 1650.0 (1350.0) | NS | 1550.0 (1300.0) | 1450.0 (750.0) | NS |
| sTNFR1 JF | 5000.0 (4500.0) | 7200.0 (4000.0) | NS | 7200.0 (5600.0) | 8400.0 (4600.0) | NS | 7200.0 (7300.0) | 5600.0 (6300.0) | NS |
| sTNFR2 S | 3000.0 (600.0) | 2800.0 (500.0) | NS | 3300.0 (1000.0) | 2800.0 (600.0) | NS | 3400.0 (2800.0) | 3300.0 (2950.0) | NS |
| sTNFR2 JF | 3500.0 (4400.0) | 4250.0 (3400.0) | NS | 4200.0 (5800.0) | 5750.0 (9000.0) | 0.017 | 4800.0 (5450.0) | 3600.0 (4200.0) | NS |
NS: non significant, IQR: interquartile range, s: soluble, S: serum, JF: joint fluid